Neurochirurgie Denys Fontaine , Christian Saleh , Aurelie Leplus Abstract Although Deep brain stimulation (DBS) is commonly used in movement disorders, it was originally developed in the 1970s to treat medically-refractory chronic pain. There are still indications for DBS, including refractory facial
Efficacy and safety of eptinezumab in adults with chronic migraine and medication-overuse headache who also received patient education: 24-week results of the randomized RESOLUTION trial
The journal of headache and pain 2026 Jun 13. doi: 10.1186/s10194-026-02423-x. Online ahead of print. Henrik W Schytz , Rigmor H Jensen , Christofer Lundqvist , Cristina Tassorelli , Fabrizio Vernieri , Michel Lantéri-Minet , Gisela M Terwindt , Andrew Blumenfeld , Stewart J Tepper , Mette Krog Josiassen , Gary
Benefits of eptinezumab on patient-reported disease burden and health-related quality of life in adults with chronic migraine and medication-overuse headache: Results from the placebo-controlled RESOLUTION trial
Cephalalgia Stewart J Tepper , Henrik W Schytz , Rigmor H Jensen , Christofer Lundqvist , Gisela M Terwindt , Cristina Tassorelli , Fabrizio Vernieri , Michel Lantéri-Minet , Andrew Blumenfeld , Mette Krog Josiassen , Gary Jansson , Anders Ettrup , Aurélia Mittoux , Richard B Lipton Abstract AimThe phase 4 RESOLUTION
Eptinezumab With Patient Education for Chronic Migraine and Medication-Overuse Headache: The Randomized, Placebo-Controlled RESOLUTION Trial
Neurology Rigmor Højland Jensen , Christofer Lundqvist , Henrik W Schytz , Cristina Tassorelli , Fabrizio Vernieri , Michel Lanteri-Minet , Gisela M Terwindt , Andrew Blumenfeld , Stewart J Tepper , Mette Krog Josiassen , Gary Jansson , Anders Ettrup , Aurélia Mittoux , Richard B Lipton Abstract Background and objectives: Medication-overuse headache
Migraine, headache disorders, and brain health: aligning advocacy with the UN Sustainable Development Goals
The journal of headache and pain Paolo Martelletti , Arão Belitardo de Oliveira , Rajinder K Dhamija , Patty Francis , Riadh Gouider , Alla Guekht , Amr Hassan Al-Hasany , Mendinatou Agbetou Houessou , Michel Lanteri-Minet , Matilde Leonardi , Martha Lu-Bolanos , Manoji Pathirage , Abdul Malik , Reza Mosaddeghi-Heris , M
Where are effective contacts located for motor cortical stimulation? A large retrospective series
Brain Stimulation 2026 Mar 30:103090. doi: 10.1016/j.brs.2026.103090. Online ahead of print. Petru Isan , Patrick Mertens , Jean-Christophe Sol , Sylvain Fowo , François Vassal , Emile Simon , Yann Seznec , Geneviève Demarquay , Jean Jacques Lemaire , Xavier Moisset , Jerôme Coste , Yann Sühan Senova , Jean Pascal Lefaucheur , Stéphane
Predictive factors of effectiveness of occipital nerve stimulation for chronic cluster headache: data from for the French ONS registry
The Journal of Headache and Pain 2026 Mar 13. doi: 10.1186/s10194-026-02319-w. Online ahead of print. Denys Fontaine, Roxane Fabre , Aurelie Leplus , Anne Donnet , Jean Regis , Anne Balossier , Christian Lucas , Nadia Buisset , Sylvie Raoul , Stéphane Derrey , Bechir Jarraya , Christelle Creach, Stéphan Chabardes, Jimmy Voirin , Sophie
Decreasing the Risk of Lead Migration in Occipital Nerve Stimulation for Cluster Headache Using Dedicated Leads
Neuromodulation 2026 Feb 25:S1094-7159(26)00015-2. doi: 10.1016/j.neurom.2026.01.009. Online ahead of print. Samia Messaoudi , Aurélie Leplus , Anne Donnet , Jean Regis , Anne Balossier , Sylvie Raoul , Geneviève Demarquay , Émile Simon , Xavier Moisset , Denis Sinardet , Jimmy Voirin , Sophie Colnat-Coulbois , Michel Lanteri-Minet , Denys Fontaine Abstract Objective: Our aim
Light-induced analgesia provides a drug-free optical method for pain relief via activation of TRAAK k+ channels
Nature communications 2026 Jan 26;17(1):620. doi: 10.1038/s41467-025-67819-w. Marion Bied , Arnaud Landra-Willm , Anne Amandine Chassot , Edward Francisco Mendez-Otalvaro , Benjamin Sueur , Kilian Roßmann , Elvira de la Peña , Pascal Fossat Stephen J Tucker , Jacques Noël , Wojciech Kopec , Felix Viana , Johannes Broichhagen , Eric Boué-Grabot
First successful protocol for desensitization to eptinezumab
Headache . 2025 Dec 19. doi: 10.1111/head.70000. Online ahead of print. Benoit Gerard , Hubert Praudel , Michel Lanteri-Minet , Elise Van Obberghen , Fanny Rocher-Moreau , Johanna Rousset , Ulysse Jacquier , Sylvie Leroy , Margot Delin Abstract Background: Eptinezumab is an anti-calcitonin gene-related peptide monoclonal antibody used for